On July 26, 2010, the State Food and Drug Administration (SFDA) was informed by Invida International Trading (Shanghai) Co., Ltd. (Invida) that LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) entrusted Invida for the voluntary recall of all batches of sodium fusidate for injection (Fucidin) from China market.

Because glass fragments have been identified in some vials of sodium fusidate for injection (Fucidin) in the batch numbers DD8874, DD9936 and DE4117, LEO Pharma A/S decided to entrust Invida to recall all batches of sodium fusidate for injection (Fucidin, Import Drug License number: H20090197) from China market in accordance with the Provisions for Drug Recall to protect the safety of patients and eliminate any potential risks.